Article Text

Download PDFPDF
Randomised controlled trial
Coronary artery bypass surgery continues to remain the treatment of choice for multivessel coronary artery disease even in the era of new-generation drug-eluting stents

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests FWM was one of the principal investigators for the SYNTAX trial.

  • Provenance and peer review Commissioned; internally peer reviewed.